Volume 55, Issue 4, Pages (April 1999)

Slides:



Advertisements
Similar presentations
Acid-base profile in patients on PD
Advertisements

RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone  Eduardo A. Slatopolsky, Steven K.
Volume 59, Issue 3, Pages (March 2001)
Volume 54, Issue 2, Pages (August 1998)
Persistent secondary hyperparathyroidism after renal transplantation
E. Cavalier, P. Delanaye, A. Carlisi, J. -M. Krzesinski, J. -P
Volume 67, Pages S1-S7 (June 2005)
Volume 73, Issue 1, Pages 3-5 (January 2008)
Volume 88, Issue 6, Pages (December 2015)
The Gutsy Side of Bone Cell Metabolism
Volume 61, Issue 3, Pages (March 2002)
Volume 67, Issue 3, Pages (March 2005)
Acid-base profile in patients on PD
Volume 61, Issue 4, Pages (April 2002)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone  Eduardo A. Slatopolsky, Steven K.
Volume 67, Issue 2, Pages (February 2005)
Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets  David M. Spiegel, Kate Brady  Kidney.
Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats  D.A. Bushinsky, K. LaPlante, J.R. Asplin 
Volume 54, Issue 4, Pages (October 1998)
Differential effects of 19-nor-1,25-(OH)2D2 and 1α-hydroxyvitamin D2 on calcium and phosphorus in normal and uremic rats  Eduardo Slatopolsky, Mario Cozzolino,
Volume 55, Issue 1, Pages (January 1999)
Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats  David A. Bushinsky, Marc D. Grynpas, John.
Volume 76, Pages S50-S99 (August 2009)
Volume 64, Issue 2, Pages (August 2003)
Volume 64, Issue 5, Pages (November 2003)
The need for reliable serum parathyroid hormone measurements
Ischemic and non-ischemic acute kidney injury cause hepatic damage
Volume 54, Issue 5, Pages (November 1998)
Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1α-hydroxylase  Mutsuko Ohnishi, Teruyo.
Use of vitamin D in chronic kidney disease patients
Volume 87, Issue 2, Pages (February 2015)
Volume 63, Issue 5, Pages (May 2003)
Chemical and hormonal determinants of vascular calcification in vitro
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Volume 54, Issue 3, Pages (September 1998)
Bisphosphonate safety and efficacy in chronic kidney disease
Volume 69, Issue 3, Pages (February 2006)
Volume 95, Issue 5, Pages (May 2019)
Blood pressure targets in hemodialysis patients
Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats  D.A. Bushinsky, A.C. Michalenka, K.L.
Persistent secondary hyperparathyroidism after renal transplantation
Volume 56, Pages S31-S37 (December 1999)
Volume 56, Issue 2, Pages (August 1999)
Volume 87, Issue 3, Pages (March 2015)
Volume 59, Issue 3, Pages (March 2001)
Volume 58, Issue 4, Pages (October 2000)
Volume 78, Issue 4, Pages (August 2010)
Volume 57, Issue 4, Pages (April 2000)
Fibroblast growth factor 23: the making of a hormone
Connections between vascular calcification and progression of chronic kidney disease: Therapeutic alternatives  Keith A. Hruska, Suresh Mathew, Matthew.
Post-transplant hypophosphatemia: Tertiary ‘Hyper-Phosphatoninism’?
Phosphate and the parathyroid
Volume 56, Issue 3, Pages (September 1999)
Volume 71, Issue 8, Pages (April 2007)
Volume 64, Issue 6, Pages (December 2003)
Volume 64, Issue 6, Pages (December 2003)
Pablo A. Ureña Torres, Marc De Broe  Kidney International 
Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats  David A. Bushinsky, M.D., Walter R. Parker,
Volume 66, Issue 6, Pages (December 2004)
Volume 64, Issue 1, Pages (July 2003)
Volume 62, Issue 5, (November 2002)
Volume 56, Issue 5, Pages (November 1999)
Volume 56, Issue 1, Pages (July 1999)
Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease  Aquiles Jara, Arnold J. Felsenfeld, Jordi.
The ins and outs of phosphate homeostasis
Control of uremic bone disease: Role of vitamin D analogs
Volume 61, Issue 4, Pages (April 2002)
Volume 55, Issue 5, Pages (May 1999)
A novel mechanism for skeletal resistance in uremia
Presentation transcript:

Volume 55, Issue 4, Pages 1434-1443 (April 1999) Phosphate depletion in the rat: Effect of bisphosphonates and the calcemic response to PTH  Aquiles Jara, Elizabeth Lee, Deborah Stauber, Farhad Moatamed, Arnold J. Felsenfeld, Charles R. Kleeman  Kidney International  Volume 55, Issue 4, Pages 1434-1443 (April 1999) DOI: 10.1046/j.1523-1755.1999.00395.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Schematic diagram of the study design. Kidney International 1999 55, 1434-1443DOI: (10.1046/j.1523-1755.1999.00395.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 The four groups were subdivided according to whether the rats were fed () or fasted () at the time blood was obtained at the end of 11days of the study diet. The serum calcium is shown in (A), and the serum phosphorus is shown in (B). LPD, low-phosphate diet; LPD + APD, low-phosphate diet plus the bisphosphonate APD; ND, normal diet; and ND + APD, normal diet plus APD. *P < 0.01 fed vs. fasted pair. Kidney International 1999 55, 1434-1443DOI: (10.1046/j.1523-1755.1999.00395.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 3 Relationship between serum calcium and parathyroid hormone (PTH) in blood collected at the end of the study diet is shown for the four groups of rats. Symbols are: () low phosphate diet (LPD); (▪) LPD + Pamidronate (APD); (○) normal diet (ND); (•) ND + APD. A sigmoidal curve would appear to best characterize the relationship. Kidney International 1999 55, 1434-1443DOI: (10.1046/j.1523-1755.1999.00395.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 4 Calcemic response to a 48-hour parathyroid hormone (PTH) infusion, defined as the increase in serum calcium from baseline (Δ serum calcium; □), as well as the pre-PTH () and post-PTH () infusion serum calcium values are shown for the four groups: LPD (low phosphate diet; N = 8), LPD + APD (LPD + Pamidronate; N = 8), ND (normal diet; N = 6), and ND + APD (N = 7). The one-way analysis of variance for the Δ calcium comparison among the four groups was P = 0.02. In addition to the differences shown in the figure, the comparison between the LPD and ND groups approached but did not attain significance (P = 0.08). The one-way analysis of variance for the pre-PTH serum calcium value among the four groups approached but did not attain significance (P = 0.07). *P < 0.05 vs. LPD and LPD + APD; +P < 0.05 vs. LPD + APD. Kidney International 1999 55, 1434-1443DOI: (10.1046/j.1523-1755.1999.00395.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 5 (A) In rats on the low phosphate diet (LPD group), the osteoblast surface (black arrow) was increased. As shown in the inset, the osteoblasts (black arrow) were in general cuboidal, and osteoblast incorporation into the osteoid matrix was commonly observed. (B) The administration of APD resulted in a marked decrease in the osteoblast surface. A representative example of an osteoid seam devoid of osteoblasts is shown in a rat on the low-phosphate diet (LPD + APD group). Abbreviations are: OS, osteoid; MB, mineralized bone. For comparison of size, 40 micron bars are included in each panel. Kidney International 1999 55, 1434-1443DOI: (10.1046/j.1523-1755.1999.00395.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 6 (A) Two osteoclasts (black arrows) on the bone surface in a rat on a normal diet (ND group). (B) The osteoclasts (black arrow) in rats on a phosphate-depleted diet (LPD group) were multinucleated and much larger than those in the rats on a normal diet. (C) In rats on the low-phosphate diet receiving APD (LPD + APD group), the osteoclasts (black arrow) were large and multinucleated. The osteoclast is on the bone surface and includes and extends beyond the area that is not in focus (the two arrows). Note the diffusely vacuolated appearance of the cytoplasm. (D) Another giant, multinucleated osteoclast from a rat on the low-phosphate diet and receiving APD (LPD + APD group). In addition to the vacuolated cytoplasm, the osteoclast is distinguished by many nuclei that are pyknotic. For size comparison, a megakaryocyte is seen immediately above the giant osteoclast. For comparison of size, 15 micron bars are included in each panel. Kidney International 1999 55, 1434-1443DOI: (10.1046/j.1523-1755.1999.00395.x) Copyright © 1999 International Society of Nephrology Terms and Conditions